ACC Rockies Chapter Please join our cardiology colleagues at the ACC Annual Meeting, a premier gathering of cardiovascular professionals from around the world. This dynamic conference brings together leading physicians, researchers, healthcare innovators, and industry experts to explore the latest advances in cardiovascular medicine. Attendees will experience cutting-edge clinical education, groundbreaking research presentations, interactive learning sessions, and exceptional networking opportunities focused on improving patient care and advancing the future of heart health.


For more information and to register, please visit: ACC Rockies Chapter Meeting 2026



ACC Live Courses
For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings

RSS Latest in Cardiology from ACC.org

  • ADHERE-ASCVD, EMAIL-HF, Remote Exercise SWEDEHEART, VIRTUES ICD Showcase Digital Solutions
    As digital health moves from promise to practice, several studies presented during a Hot Line Session at ESC Congress 2026 demonstrate how technology can accelerate the implementation of guideline-directed cardiovascular care. From digital strategies that support uptake of SGLT2 inhibitors in patients with heart failure (HF) to remotely delivered exercise programs, targeted outreach to improve […]
  • NATURE Superiority: Stent Retriever Thromboectomy Plus PCI in Patients With MI
    Compared with conventional PCI alone, stent-retriever thrombectomy followed by PCI was associated with reduced infarct size in patients with large thrombus burden undergoing primary PCI less than eight hours from symptom onset, based on findings from the NATURE Superiority study presented at ESC Congress 2026 and simultaneously published in JACC.
  • AIR-STEMI, PRESC1SE-MI and TARGET CTA Highlight Critical Care Cardiology Science
    Researchers presenting findings from the AIR-STEMI trial at ESC Congress 2026 said a strategy of complete coronary artery revascularization guided by functional coronary angiography resulted in a lower risk of death, myocardial infarction (MI), cerebrovascular accident, or ischemia-driven revascularization in patients with STEMI and multivessel coronary artery disease compared with conventional angiography.
  • Interventional Highlights From LIBREXIA ACS, PREMIUM, SWITCH SWEDEHEART, A-CLOSE, EPIDAURUS
    Interventional science was the focus of a Hot Line Session at ESC Congress 2026, with studies shedding light on milvexian with antiplatelet therapy following an acute coronary event; aspirin omission at the time of primary PCI in STEMI; switching from ticagrelor to prasugrel following PCI in patients with acute coronary syndrome (ACS); clopidogrel vs. extended […]
  • DAN-RSV: Analyses Compare RSVpreF Vaccine With No Vaccine
    Adults who received the bivalent RSV prefusion F (RSVpreF) vaccine, compared with no vaccine, had a lower incidence of hospitalizations for respiratory syncytial virus (RSV)-related respiratory illness, based on expanded findings from the DAN-RSV trial presented at ESC Congress 2026 and simultaneously published in NEJM Evidence.